Your prediction
Pros and Cons of Curatis Holding AG in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved
Curatis: Double-digit revenue growth in 2025
and major milestones for corticorelin achieved
Curatis and Neupharma announce exclusive licensing agreement to develop and market corticorelin (C-PTBE-01) for the treatment of peritumoral brain edema in Japan
Curatis and Neupharma announce exclusive licensing
agreement to develop and market corticorelin (C-PTBE-01)
for the treatment of peritumoral brain edema in Japan
Curatis Holding AG announces CHF 1.2 million private placement with strategic investor
Curatis Holding AG announces CHF 1.2 million private placement with strategic investor